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(57) ABSTRACT 
Various embodiments of the present invention provide a con-
duit device including an attaching device configured for 
defining a helical pathway through a tissue wall and comple-
mentary ring in cooperation for securing the device within an 
aperture defined in the tissue wall. Some embodiments of the 
present invention further provide a system for implanting a 
conduit device in a tissue wall. More specifically, some 
embodiments provide a system including a coring device for 
defining an aperture in a tissue by removing and retaining a 
tissue core and securely implanting a conduit device therein 
so as to provide fluid communication between a first and 
second surface of the tissue wall via the conduit device. 
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CONDUIT DEVICE AND SYSTEM FOR 
IMPLANTING A CONDUIT DEVICE IN A 
TISSUE WALL 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
2 
through the heart muscle and into the left ventricle. Once the 
sutures are in place, a ventricular coring device is used to 
remove a core of ventricular muscle, and the pre-threaded 
sutures are then pulled to draw the connector into the opening 
until the cuff comes to rest: on the apex. The sutures are tied 
off, and additional sutures may be added. Either before or 
after this procedure, the opposite end of the connector is 
attached to a valved conduit which terminates at the aorta. 
The current techniques and technology available to per-
The present application is a continuation of copending U.S. 
patent application Ser. No. 13/845,960, filed on Mar. 18, 
2013, which is a continuation of U.S. patent application Ser. 
No. 12/901,810, filed on Oct. 11, 2010, now U.S. Pat. No. 
8,430,836 issued on Apr. 30, 2013, which is a continuation of 
U.S. patent application Ser. No. 11/739,151, filed on Apr. 24, 
2007, now U.S. Pat. No. 7,846,123 issued on Dec. 7, 2010, 
which are hereby incorporated by reference in their entirety 
herein. 
10 formAAC insertion were originally designed to be performed 
on-pump; either with an arrested or fibrillating heart. While 
off-pump cases have been described, they can be technically 
difficult due to the shortcomings of presently available con-
duits and systems for installing such conduits. For example, 
FIELD OF INVENTION 
15 because existing conduits require the use of sutures to reliably 
secure the connector in place, it is often difficult for surgeons 
or other clinicians to insert such sutures reliably in active 
cardiac and/or vascular tissue. 
Some devices and methods have been devised to install an 
This invention relates to devices and methods for creating 
and maintaining a fluid conduit to establish fluid communi-
cation between opposing surfaces of a tissue wall. 
BACKGROUND OF THE INVENTION 
20 AAC conduit, such as those described generally in U.S. patent 
application Ser. No. 11/251,100, filed on Oct. 14, 2005, and 
U.S. patent application Ser. No. 10/915,691, filed on Aug. 11, 
2004, both of which are hereby incorporated herein in their 
entirety by reference. However, these AAC conduit devices 
Construction of an alternative conduit between the left 
ventricle and the aorta (an apicoaortic conduit, or AAC) to 
create a double-outlet left ventricle (LV) has been success-
fully employed to treat a variety of complex congenital LV 
outflow obstruction (fibrous tunnel obstruction, aortic annu-
25 and installation systems rely on the use of a flexible flange 
that is inserted through a pre-defined aperture in the ventricu-
lar apex. Thus, such methods require the use of a hemostatic 
device (such as an occlusion balloon and/or "umbrella" 
device) to prevent blood loss from the aperture during instal-
30 lation oftheAAC conduit. 
lar hypoplasia, tubular hypoplasia of the ascending aorta, and 
patients with diffuse septa! thickening, severe LV hypertro-
phy and a small LV cavity) as well as adult-onset aortic 
stenosis in patients with complicating preoperative condi-
tions (previous failed annular augmentation procedures, pre- 35 
vious infection, previous CABG with patent anterior internal 
mammary artery grafts, and a porcelain ascending aorta). 
However, the AAC insertion procedure has been poorly 
accepted, primarily because of early valve failures using first-
generation bioprostheses as well as the success of direct 40 
LVOTO repair and aortic valve replacement. In the United 
States, despite an aging population, the unadjusted mortality 
for isolated aortic valve operations in 2001 remained under 
4%. Further, the AAC insertion operation, with or without 
cardiopulmonary bypass, has not been as technically straight- 45 
forward as direct aortic valve replacement. For most sur-
geons, AAC insertion is not a familiar operation and is of 
historical interest only. 
Nonetheless, several studies have demonstrated that AAC 
insertion successfully lessens the LY-aortic pressure gradient, 50 
preserves or improves ventricular function and maintains nor-
mally distributed blood flow through the systemic and coro-
nary circulation. While there have been several techniques 
described, the most commonly employed method is the lat-
eral thoracotomy approach with placement of the AAC to the 55 
descending aorta. Other techniques include a median sterno-
tomy approach with insertion of the distal limb of the AAC to 
the ascending aorta, to the transverse part of the aortic arch, or 
to the intra-abdominal supraceliac aorta. 
In general, the thoracic aorta and the left ventricle apex are 60 
exposed through a left lateral thoracotomy, and a needle is 
passed through the apex and into the left ventricle. While the 
connector is still spaced apart from the apex, the sutures that 
will fix the connector to the apex are threaded through a cuff 
on the connector and through the apex in a matching pattern. 65 
The cuff is set back from the end of the connector by 1-2 
centimeters to allow the end of the connector to extend 
SUMMARY OF THE INVENTION 
Various embodiments of the present invention provide an 
improved system and method for the insertion of a conduit 
(such as anAAC conduit) that will significantly simplify the 
in vivo insertion of a graft into the beating cardiac apex or 
other tissue walls (such as other areas of the heart including 
the anterior, lateral, posterior walls of the left or right ven-
tricle, the left or right atrium, the aortic wall, ascending, 
transverse, or descending, or other blood vessel walls), such 
that vascular conduit insertions (including AAC procedures) 
may be rendered far more attractive to clinicians. Because 
vascular conduits and systems of the present invention may be 
used to create alternate outflow tracts in "off-pump" proce-
dures, the embodiments of the present invention may effec-
tively reduce and/or negate the detrimental effects of both 
cardio-pulmonary by-pass (CPB) and global cardiac 
ischemia. Additionally, because some conduit embodiments 
of the present invention (for AAC procedures, for example) 
may be inserted into a ventricular or atrial free wall or cardiac 
apex, the conduction system of the heart may be avoided, 
along with the native coronary arteries and grafts from pre-
vious surgical revascularization. In some embodiments of the 
present invention, wherein the system is used to implant an 
AAC, a small size valve (19 to 21 mm for typical adult body 
surface areas) is usually adequate; as the effective postopera-
tive orifice is the sum of the native and prosthetic aortic 
valves. Further, the present invention provides vascular con-
duits that may be compatible with newer generation biologic 
valves, such that valved conduit failure is far less likely. 
Various embodiments of the present invention may also pro-
vide general conduit devices (and systems for implanting) 
suitable for establishing fluid communication between 
opposing surfaces of tissue walls in a variety of applications, 
including the establishment of a fluid conduit through the 
tissue wall of a manimalian urinary bladder. 
US 9,308,015 B2 
3 
In one exemplary embodiment, a system is provided for 
implanting a conduit device (such as anAAC component) in 
4 
engaged with a proximal end of the outer tube and the inner 
tube may comprise a complementary second securing device 
operably engaged with a proximal end of said inner tube. 
Thus, according to such embodiments, the second securing 
device may be configured for selectively operably engaging 
the first securing device so as to operably engage the inner 
tube with the outer tube to install and maintain the conduit. 
In some embodiments, the system may also comprise a 
coring device configured for advancing through the conduit 
aperture defined by the inner tube and through the tissue wall 
to define an aperture therein by removing a tissue core. The 
coring device may be further configured for carrying the inner 
tube through the aperture such that the inner tube extends at 
least partially through the aperture so as to establish fluid 
communication between the first and second surfaces of the 
a tissue wall having a first surface and an opposing second 
surface. According to some embodiments, the system com-
prises an outer tube defining a guide aperture extending axi-
ally through the outer tube and an attaching device extending 
from a distal end of said outer tube. The attaching device is 
configured for advancing along a helical path at least partially 
through the tissue wall such that at least a portion of the 
attaching device becomes disposed substantially between the 10 
first surface and the opposing second surface of the tissue wall 
when the outer tube is rotated relative to the first surface of the 
tissue wall. The attaching device, in some system embodi-
ments, comprises at least one of a helical static coil and a 
helical elastic spring having a sharpened distal end adapted 
for piercing the tissue wall as the outer tube is rotated relative 
15 tissue wall. The coring device may define a coring bore 
extending axially therethrough and configured for receiving 
the tissue core removed by the coring device. In some 
embodiments, the coring device may further comprise a 
piercing rod slidably advancable and retractable within the 
to the first surface of the tissue wall. According to some such 
embodiments, the attaching device may define a radially-
expanding helix as the attaching device extends away from 
the distal end of the outer tube. 
In some embodiments, the system also comprises a ring 
operably engaged about an outer surface of the outer tube and 
configured for cooperating with the attaching device such that 
at least a portion of the tissue wall is secured between the 
attaching device and the ring so as to operably engage said 
outer tube with the tissue wall. According to some such 
embodiments, the system may further comprise a plurality of 
ridges disposed on the outer surface of the outer tube. In such 
embodiments, the ring comprises at least one deformable 
pawl member operably engaged therewith for releasably 
engaging the plurality of ridges on the outer surface of the 
outer tube. In some other embodiments, the system may com-
prise threading on at least a portion of the outside surface of 
the outer tube and corresponding threading on at least a por-
tion of an inside surface of the ring. The threading may thus be 
configured to cooperate for axially securing the ring relative 
to the outer tube. Furthermore, some system embodiments 
may further comprise a nut operably engaged about an outer 
surface of the outer tube and proximal to the ring. The nut may 
comprise threading on at least a portion on an inside surface 
thereof, wherein the threading may be configured for coop-
erating with the threading on at least a portion of the outside 
surface of the outer tube. Furthermore, the nut may be con-
figured for cooperating with the ring to advance the ring 
towards the distal end of the outer tube. 
In some embodiments, various system components, such 
as the outer tube and the ring, may be configured to conform 
to and/or establish a substantially fluid-tight seal with at least 
a portion a surface of the tissue wall. For example, in some 
embodiments, the system may comprise a sealing member 
operably engaged with a distal end of the ring. According to 
such embodiments, the sealing member may be configured 
for establishing a substantially fluid tight seal between the 
ring and the first surface of the tissue wall. In some embodi-
ments, the system may be configured to cooperate and/or 
operably engage a tissue wall comprising a substantially 
curved tissue wall. According to some such embodiments, the 
ring may comprise a frusto-conical assembly configured for 
receiving at least a portion of the substantially curved tissue 
wall so as to form a substantially fluid-tight seal between the 
frusto-conical assembly and the tissue wall. 
20 coring bore. The piercing rod may further comprise a retrieval 
device operably engaged with a distal end thereof and con-
figured for axially retaining the tissue core removed by the 
coring device. Thus, in some embodiments, the piercing rod 
may be configured for advancing so as to pierce the tissue wall 
25 prior to removal of the tissue core and/or retracting after 
removal of the tissue core such that the tissue core is retriev-
able via a proximal end of the coring device. In some such 
embodiments, the coring device may further comprise a 
handle operably engaged with the proximal end of the coring 
30 
device. The handle may define a tissue core chamber in com-
munication with the coring bore, the tissue core chamber 
configured for receiving the tissue core retrieved by the 
retraction of the piercing rod. Furthermore, in some such 
embodiments, at least a portion of the handle may comprise a 
transparent material such that the tissue core received therein 
35 is visible from a position outside the handle. 
The various embodiments of the present invention may 
thus be configured for implanting a conduit device that is 
adapted for providing a conduit for a medical procedure. Such 
procedures may include, but are not limited to: bypass; car-
40 diac valve repair or replacement; attachment of a ventricular 
assist device; establishment of an apicoaortic conduit (AAC) 
and combinations of such procedures. 
Use of this new conduit device, system, and method will 
significantly improve the ease and safety of conduit insertion 
45 (such as the implantation of AAC devices, for example). For 
example, various embodiments of the present invention may 
allow the outer tube to be securely operably engaged with the 
tissue wall (due at least in part to the cooperation of the 
attaching device and the ring) prior to the removal of a tissue 
50 core to define an aperture in the tissue wall. Thus, portions of 
the system disclosed herein may define a guide aperture 
extending axially through the outer tube for receiving a coring 
device that may be configured to be capable of efficiently 
removing and retrieving a tissue core while substantially 
55 simultaneously operably engaging a inner tube in the guide 
aperture so as to establish fluid communication between first 
and second opposing surfaces of the tissue wall. As persons of 
ordinary skill in the art will readily appreciate, the various 
embodiments of the present invention may also be used in a 
60 minimally invasive, endoscopically assisted approach. 
In some embodiments, the system further comprises an 
inner tube configured for insertion into the guide aperture 
defined by the outer tube. According to such embodiments, 
the inner tube defines a conduit aperture extending axially 65 
therethrough. Furthermore, in some such embodiments, the 
outer tube may comprise a first securing device operably 
BRIEF DESCRIPTION OF THE DRAWINGS 
Having thus described various embodiments of the inven-
tion in general terms, reference will now be made to the 
accompanying drawings, which are not necessarily drawn to 
scale, and wherein: 
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FIG. 1 shows a non-limiting perspective view of an exem-
plary system for implanting a conduit device, according to 
one embodiment of the present invention; 
FIG. 2 shows a non-limiting side cross-sectional view of an 
exemplary system for implanting a conduit device, according 
to one embodiment of the present invention; 
FIG. 3 shows a non-limiting side cross-sectional view of an 
exemplary conduit device implanted in a tissue wall, accord-
ing to one embodiment of the present invention; 
FIG. 4 shows a non-limiting side view of an exemplary 10 
system for implanting a conduit device, according to one 
embodiment of the present invention; 
FI GS. SA-SG show an exemplary set of views of the instal-
lation of a conduit device using an exemplary system, accord- 15 
ing to one embodiment of the present invention; 
FIG. SA shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com-
prising an attaching device at least partially implanted in a 
tissue wall, according to one embodiment of the present 20 
invention; 
FIG. SB shows a non-limiting side cross-sectional view of 
6 
FIG. 7 shows a non-limiting perspective view of an exem-
plary conduit device comprising an attaching device compris-
ing a helical spring, according to one embodiment of the 
present invention. 
DETAILED DESCRIPTION OF THE INVENTION 
The present inventions now will be described more fully 
hereinafter with reference to the accompanying drawings, in 
which some, but not all embodiments of the inventions are 
shown. Indeed, these inventions may be embodied in many 
different forms and should not be construed as limited to the 
embodiments set forth herein; rather, these embodiments are 
provided so that this disclosure will satisfy applicable legal 
requirements. Like numbers refer to like elements through-
out. The singular forms "a," "an," and "the" include plural 
referents unless the context clearly dictates otherwise. 
Although some embodiments of the invention described 
herein are directed to a conduit device 1 (see FIGS. 1 and 7, 
for example) and a system for implanting such a device to 
form an apicoaortic connector (AAC) between the cardiac 
apex and the aorta, it will be appreciated by one skilled in the 
art that the invention is not so limited. For example, aspects of 
the conduit device 1 and systems of the present invention can 
an exemplary system for implanting a conduit device com-
prising an attaching device and a ring cooperating to secure at 
least a portion of the tissue wall between the attaching device 
and the ring so as to operably engage said outer tube with the 
tissue wall, according to one embodiment of the present 
invention; 
25 also be used to establish and/or maintain conduits in a variety 
of tissue structures using minimally-invasive and/or invasive 
delivery techniques. Furthermore, while the embodiments of 
the invention described herein are directed to the thoraco-
FIG. SC shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com- 30 
prising a coring device carrying an inner tube configured for 
insertion into a guide aperture defined by the outer tube, 
wherein the coring device is advanced at least partially 
through the tissue wall so as to remove a tissue core thereof, 35 
according to one embodiment of the present invention; 
FIG. SD shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com-
prising a coring device carrying an inner tube configured for 
insertion into a guide aperture defined by the outer tube, 40 
wherein the coring bore defined by the coring device contains 
a tissue core removed from the tissue wall, according to one 
embodiment of the present invention; 
FIG. SE shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device com- 45 
prising a coring device carrying an inner tube configured for 
insertion into a guide aperture defined by the outer tube, 
wherein a piercing rod is retracted through the coring bore 
after removal of the tissue core such that the tissue core is 
retrievable via a proximal end of the coring device, according 50 
to one embodiment of the present invention; 
FIG. SF shows a non-limiting side cross-sectional view of 
an exemplary system for implanting a conduit device, 
wherein the outer tube and innertube are installed in the tissue 
55 
wall so as to establish fluid communication between the first 
and second surfaces of the tissue wall, according to one 
embodiment of the present invention; 
FIG. SG shows a non-limiting side cross-sectional view of 
scopic implantation of the conduit device to form at least one 
port for establishing anAAC, it should be understood that the 
system and/or vascular conduit device embodiments of the 
present invention may be used to establish valved and/or open 
conduits (including bypass conduits) to augment native blood 
vessels in order to treat a variety of vascular conditions 
including, but not limited to: aortic valvular disease, conges-
tive heart failure, left ventricle outflow tract obstructions 
(LVOTO), peripheral arterial obstructions, small vessel 
obstructions, and/or other conditions. Furthermore, the vas-
cular conduit device and system of the present invention may 
also be used to establish a port for inter-ventricular repairs 
such as, for example, valve repair and/or replacement or 
ablation procedures. Thus, the conduit device 1 described in 
further detail below may also comprise a threaded fluid-tight 
cap, and/or a cap having at least one pawl member (for engag-
ing corresponding ridges defined on an outer surface of the 
conduit device 1) for selectively sealing a proximal end of the 
conduit device 1 such that the inner tube 40 thereof may serve 
as a re-usable port for repairing and/or treating diseased por-
tions of the cardiac anatomy. Furthermore, the conduit device 
1 and system embodiments of the present invention may also 
be used to implant a conduit and/or port for left ventricular 
assist devices. 
It should be further understood that various embodiments 
of the conduit device 1 described herein may also be utilized 
to establish fluid communication between opposing surfaces 
of a variety of tissue walls and/or anatomical structures. For 
example, in some embodiments, the conduit device 1 and 
system for implanting described herein may be used to estab-
lish a conduit (and consequently fluid communication) 
an exemplary coring device, wherein a handle operably 
engaged with a proximal end of the coring device contains a 
tissue core removed from the tissue wall by the coring device, 
according to one embodiment of the present invention; 
60 between opposing surfaces of a wall of an anatomical struc-
ture that may include, but is not limited to: a urinary bladder; 
a gall bladder; a diaphragm; a thoracic cavity; an abdominal 
cavity; an intestinal structure; a cecal cavity; and other tissue 
wall structures. FIG. 6 shows a non-limiting side view of an exemplary 
coring device carrying an inner tube configured for insertion 65 
into a guide aperture defined by the outer tube, according to 
one embodiment of the present invention; and 
It should be understood that the various conduit device 1 
components described herein (see, for example, the compo-
nents shown in FIG. 1) may comprise a variety ofbiocom-
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outer surface of the innertube 40 so as to establish a substan-
tially fluid-tight seal between the outer surface of the inner 
tube 40 and the portion of the tissue wall 8SO that has been 
urged radially inward. Furthermore, in some such embodi-
ments, the radially-expanding helix of the attaching device lS 
may correspond, for example, to a ring 30 comprising a 
frusto-conical assembly configured for receiving at least a 
portion of a substantially curved tissue wall 8SO (see, for 
example, FIG. SB) so as to forma substantially fluid-tight seal 
between the frusto-conical assembly of the ring 30 and the 
tissue wall 8SO. 
In other embodiments, as shown generally in FIG. 7, the 
attaching device lS may comprise a helical spring and/or coil 
having a substantially constant helical diameter as the attach-
ing device lS extends away from the distal end of the outer 
tube 10. The substantially consistent helical diameter of the 
attaching device lS shown generally in FIG. 7 may be useful 
for operably engaging the outer tube 10 with a substantially 
flat tissue wall 8SO. Furthermore, as shown generally in FIG. 
7, in some embodiments, the corresponding ring 30 (and the 
corresponding sealing member 3S that may be operably 
engaged therewith) may also be configured to provide a sub-
stantially flat and/or disc-shaped sealing surface that may be 
suitable for seating on and/or establishing a substantially 
patible materials including, but not limited to: stainless steel; 
titanium substantially rigid biocompatible polymers; elasto-
meric biocompatible polymers; and combinations of such 
materials. For example, in some embodiments, the outer tube 
10, ring 30, nut 20, and inner tube 40 may comprise substan- 5 
tially rigid biocompatible polymers. In some embodiments, 
the attaching device lS may comprise a biocompatible metal 
and/or metal alloy that may be embedded substantially within 
and/or operably engaged with an injection-molded polymer 
used to form the outer tube 10. Furthermore, as described 10 
further herein, some embodiments of the present invention 
may further comprise a sealing member 3S operably engaged 
with a distal end of the ring 30. In such embodiments, the 
sealing member 3S may comprise a substantially compliant 
biocompatible polymer (such as an elastomeric polymer) that 15 
may be suitable for establishing a substantially fluid tight seal 
between the ring 30 a surface of the tissue wall 8SO. Similarly, 
the various components of the coring device 2 described 
herein may also comprise a combination of biocompatible 
materials suitable for removing and retaining the tissue core 20 
8SOa in order to define an aperture in the tissue wall 8SO such 
that the inner tube 40 may be installed to establish fluid 
communication between the opposing first and second sur-
faces 8SS, 8S3 of the tissue wall 8SO (as shown in FIG. 3, for 
example). 
FIG. 3 shows some exemplary components of a system for 
implanting a conduit device 1 in a tissue wall 8SO having a 
first surface 8SS and an opposing second surface 8S3. As 
shown generally in FIGS. 1and2, such a system may com-
prise an outer tube 10 defining a guide aperture extending 30 
axially therethrough and an attaching device lS extending 
from a distal end of the outer tube 10. As shown in FIG. 3, for 
example, the attaching device lS may be configured for 
advancing along a helical path at least partially through the 
tissue wall 8SO such that at least a portion of the attaching 35 
device lS becomes disposed substantially between the first 
surface 8SS and the opposing second surface 8S3 of the tissue 
wall 8SO when the outer tube 10 is rotated relative to the first 
surface 8SS of the tissue wall 8SO. As shown generally in FIG. 
25 fluid-tight seal with a substantially flat first tissue surface 8SS 
that may surround an aperture defined in a correspondingly 
flat tissue wall 8SO. 
2, the attaching device lS may be integrally formed within the 
outer tube 10. For example, the attaching device lS may, in 
some embodiments, be placed at least partially in a mold such 
that the polymeric or other components of the outer tube 10 
may be molded substantially around at least a portion of the 
attaching device lS (which may comprise a static coil and/or 
elastic spring, as described further herein). In other embodi-
ments, the attaching device lS may be operably engaged with 
at least a portion of the outer tube 10 via adhesive, RF weld-
ing, and/or other attachment methods that may be suitable for 
securely operably engaging the attaching device lS to the 
outer tube 10. 
The attaching device lS may comprise, in some embodi-
ments, a helical static coil having a sharpened distal end 
adapted for piercing the tissue wall 8SO as the outer tube 10 is 
rotated relative to the first surface 8SS of the tissue wall 8SO. 
In other embodiments, the attaching device lS may comprise 
a helical elastic spring having a sharpened end adapted for 
piercing the tissue wall 8SO as the outer tube 10 is rotated 
relative to the first surface 8SS of the tissue wall 8SO. In some 
embodiments, as shown in FIG. 4, wherein the attaching 
device lS comprises a helical spring and/or coil, the spring 
and/or coil may device a radially-expanding helix as the 
attaching device lS extends away from the distal end of the 
outer tube 10. In some embodiments, wherein the attaching 
device comprises a conical and/or "radially-expanding" 
helix, the attaching device lS may act to compress at least a 
portion of the tissue wall 8SO radially inward and towards an 
As described herein, the system may further comprise a 
ring 30 operably engaged about an outer surface of the outer 
tube 10. As shown generally in FIGS. 3 and SB, the ring 30 
may be configured for cooperating with the attaching device 
lS such that at least a portion of the tissue wall 8SO is secured 
between the attaching device lS and the ring 30 so as to 
operably engage the outer tube 10 with the tissue wall 8SO. 
Some embodiments may further comprise a plurality of 
ridges 11 and/or threads disposed on the outer surface of the 
outer tube 10. According to such embodiments, the ring 30 
may comprise at least one deformable pawl member config-
ured for releasably engaging the plurality of ridges 11 dis-
40 posed on the outer surface of the outer tube 10. Other embodi-
ments (as shown generally in FIG. 2, for example), may also 
further comprise threading 11 on at least a portion of the 
outside surface of the outer tube 10 and corresponding thread-
ing on at least a portion of an inside surface of the ring 30. The 
45 threading 11 (and corresponding threading on the inner sur-
face of the ring 30) may be being configured to cooperate for 
axially securing the ring 30 relative to the outer tube 10. As 
shown generally in FIGS. SA-SB, some embodiments may 
further comprise a nut 20 operably engaged about an outer 
50 surface of the outer tube 10 and proximal to the ring 30. 
According to such embodiments, the nut 20 may comprise 
threading on at least a portion on an inside surface of the nut 
20. The threading disposed on the inside surface of the nut 20 
may be configured for cooperating with the threading 11 on at 
55 least a portion of the outside surface of the outer tube 11 for 
axially securing the nut 20 relative to the outer tube 10 and the 
adjacent ring 20. As shown in FI GS. SA-SB, the nut 20 may be 
configured for cooperating with the ring 30 to advance the 
ring 30 towards the distal end of the outer tube 10. As shown 
60 generally in FIGS. SA-SB, the attaching device lS may pro-
vide counter-traction so as to allow for the rotation (and 
resulting advancement) of the nut 20 (and the ring 30 dis-
posed distally thereto) such that rotation of the nut 20 (and the 
corresponding movement of the ring 30 toward the first tissue 
65 surface 8SS) may draw at least a portion of the tissue wall 8SO 
into engagement with an inner surface of the ring 30 such that 
the conduit device 1 (and particularly the outer tube 10 
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seal testing aperture 36) and the tissue wall 8SO may thus 
reduce a chance that the ring 30 (and the helical attaching 
device lS extending from the outer tube 10) are rotatable 
relative to the tissue wall 8SO such that the ring 30 and the 
thereof) is stabilized, engaged in a substantially fluid tight 
seal, and/or operably engaged with respect to the tissue wall 
8SO prior to the use of a coring device 2 for removing a tissue 
core 8SOa via the guide aperture defined axially through the 
outer tube 10. 5 helical attaching device lS may be less prone to "backing out" 
of the tissue wall 8SO once the seal is established between the In order to ensure that the ring 30 forms a substantially 
fluid-tight seal with the first surface 8SS of the tissue wall 8SO 
about the aperture defined therein, some embodiments (as 
shown in FIG. 1, for example) may further comprise a sealing 
member 3S operably engaged with a distal end of the ring 30. 10 
The sealing member 3S may comprise, for example, a gasket 
ring 30 and the first surface 8SS of the tissue wall 8SO. 
In some additional embodiments, as shown generally in 
FIG. 7, thering 30 (and/or the sealingmember3S that maybe 
operably engaged therewith) may define a substantially flat 
and/or disc-shaped annular sealing surface that may be con-
or other elastomeric component configured for establishing a 
substantially fluid tight seal between the ring 30 and the first 
surface 8SS of the tissue wall 8SS. As described herein, some 
embodiments of the present invention may be configured for 15 
establishing fluid communication between the opposing sides 
figured for establishing a substantially fluid-tight seal 
between the ring 30 and a substantially flat first tissue surface 
8SS about an aperture defined in the tissue wall 8SO. 
Referring to FIG. SC, for example, some embodiments 
may further comprise an inner tube 40 defining a conduit 
aperture extending axially therethrough. The inner tube 40 
may be configured for insertion into the guide aperture 
defined by the outer tube 10. In some embodiments, as shown 
in FIG. 6, the inner tube 40 may be carried by a coring device 
2 that may be advanced through the guide aperture defined by 
of the walls of a manimalian heart (such as the ventricular 
apex, for example). In such embodiments, the conduit device 
1 may be required to be operably engaged with a substantially 
curved tissue wall 8SO (see FIG. SA, for example). In such 20 
embodiments, the ring 30 may comprise a frusto-conical 
assembly configured for receiving at least a portion of the 
substantially curved tissue wall 8SO so as to form a substan-
tially fluid-tight seal between the frusto-conical assembly of 
the ring 30 and the tissue wall 8SO. As shown, for example, in 25 
FIG. SB, in some embodiments, the ring 30 may be urged 
towards a distal end of the outer tube 10 by the rotation of a nut 
the outer tube 10 and configured for substantially simulta-
neously removing a tissue core 8SOa to define an aperture in 
the tissue wall 8SO and operably engaging the inner tube 40 
with the outer tube 10 so as to establish and/or maintain a 
reliable and engageable pathway for fluid communication 
between the first and second surfaces 8SS, 8S3 of the tissue 
wall 8SO. In order to facilitate the secure engagement of the 
outer tube 10 with the inner tube 40, some conduit device 1 
embodiments may comprise a first securing device 13 oper-
ably engaged with a proximal end of the outer tube 10 and a 
20 about threading 11 disposed on an outer surface of the 
outer tube 10. Thus, according to some such embodiments, 
the cooperation of the attaching device lS (which may com- 30 
prise a piercing helical spring and/or coil, for example) with 
the ring 30 may act to draw at least a portion of the curved 
tissue wall 8SO into the frusto-conical assembly of the ring 30 
such that a substantially fluid-tight seal may be formed and 
maintained between the frusto-conical assembly of the ring 35 
30 and the tissue wall 8SO. In some conduit device 1 embodi-
complementary second securing device 43 operably engaged 
with a proximal end of the inner tube 40. According to such 
embodiments, as shown generally in FIG. 2, the second secur-
ing device 43 may be configured for selectively operably 
engaging the first securing device 13 so as to operably engage 
ments, as shown generally in FIG. 2, the ring 30 may com-
prise a seal testing aperture 36 that may allow a clinician to 
selectively test whether or not a substantially fluid-tight seal 
has been established between the ring 30 and the first surface 
8SS of the tissue wall 8SO when the ring 30 is moved towards 
the distal end of the outer tube 10 and into engagement with 
the tissue wall 8SO. For example, a clinician may operably 
engage a fluid source (such as a saline solution bag) with the 
seal testing aperture 36 (which may comprises a luer lock 
connector or other connector for operably engaging the fluid 
source) and introducing a fluid via seal testing aperture 36 and 
observing the interface between the ring 30 and the first 
surface 8SS of the tissue wall 8SO to see if any substantial 
amount of fluid emerges. If no fluid is readily visible, a 
clinician may be reasonably assured that the seal formed 
between the ring 30 and the tissue wall 8SO is substantially 
fluid-tight. By assessing the seal formed between the ring 30 
and the tissue wall 8SO, a clinician may determine if it is 
medically safe to introduce the coring device 2 via the guide 
conduit defined in the outer tube 10 (i.e. determine if blood 
loss is likely to occur between the ring 30 and the first surface 
8SS of the tissue wall 8SO when the coring device 2 (and the 
coring cylinder 6S thereof) is advanced through the tissue 
wall 8SO as shown in FIG. SC). 
In some embodiments, the seal testing aperture 36 may also 
serve an alternative function for rotationally securing the ring 
30 relative to and the first surface 8SS of the tissue wall 8SO. 
For example, a clinician may insert a needle and/or other 
elongate spike through the seal testing aperture 36 defined in 
the ring 30 and substantially into the tissue wall 8SO. The 
interaction of the needle and/or spike with the ring 30 (via the 
the inner tube 40 with the outer tube 10. As shown generally 
in FIG. 6, the second securing device 43 may comprise one or 
more deformable pawls configured for selectively operably 
40 engaging the first securing device 13 as shown in FIG. 2 
(wherein the first securing device 13 comprises one or more 
ridges disposed on a proximal portion of the outer surface of 
the outer tube 10). 
As shown generally in FIG. 6, some system embodiments 
45 for installing a conduit device 1 may further comprise a 
coring device 2 configured for advancing through the conduit 
aperture defined by the inner tube 40 and through the tissue 
wall 8SO to define an aperture therein by removing a tissue 
core 8SOa (see FIG. SD, for example, showing the coring 
50 device 2 removing a tissue core 8SOa and collecting the tissue 
core 8SOa in a coring bore defined by a coring cylinder 6S. As 
shown generally in FIGS. SC and 6, the coring device 2 may 
be further configured for carrying the inner tube 40 through 
the aperture such that the inner tube 40 extends at least par-
55 tially through the aperture (see FIG. SF, for example) so as to 
establish fluid communication between the first 8SS and sec-
ond 8S3 surfaces of the tissue wall 8SO. In some embodi-
ments, as shown in the cross-sectional side view of FIG. SD, 
the coring device 2 (and/or the coring cylinder 6S thereof) 
60 defines a coring bore extending axially therethrough config-
ured for receiving the tissue core 8SOa removed by the coring 
cylinder 6S. 
As shown in FIGS. SC-SE, the coring device 2 may also 
comprise a piercing rod 60 slidably advancable and retract-
65 able within the coring bore defined by the coring device 2. 
The piercing rod 60 may further comprise a retrieval device 
61 operably engaged with a distal end thereof and configured 
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for axially retaining the tissue core 8SOa removed by the 
coring cylinder 6S. In various embodiments, the retrieval 
device 61 may include, but is not limited to: a barb; a hook; 
corkscrew; expandable balloon; a self-expanding structure; 
and/ or other device configured for initially piercing the tissue 
wall 8SO so as to be capable of retrieving the tissue core 8SOa 
removed by the coring device 2 as described further herein. 
As shown generally in FIG. SC, the piercing rod 60 may be 
configured for advancing so as to pierce the tissue wall 8SO 
prior to removal of the tissue core 8SOa (i.e. prior to the 
advancement of the coring cylinder 6S through the tissue wall 
8SO). Furthermore, as shown generally in FIG. SE, the pierc-
ing rod 60 may be further configured for retracting after 
removal of the tissue core 8SOa such that the tissue core 8SOa 
is retrievable via a proximal end of the coring device 2. In 
some system embodiments for installing a conduit device 1, 
the coring device 2 may further comprise a handle 63 oper-
ably engaged with a proximal end of the coring device 2 
(and/or a proximal end of the coring cylinder 6S). According 
to such embodiments, as shown generally in FIG. 6, the 
handle 63 may define a tissue core chamber 62 in communi-
cation with the coring bore defined by the coring cylinder 6S. 
12 
the attaching device lS comprises a conical and/or "radially-
expanding" helix, the attaching device lS may act to com-
press at least a portion of the tissue wall 8SO radially inward 
such that the portion of the tissue wall 8SO may be more 
readily received by ring 30 (which may comprise a frusto-
conical structure configured for receiving the compressed 
portion of the tissue wall 8SO). As shown in FIG. SB, the 
conduit device 1 installation process may continue with the 
advancement and/or tightening of the ring 30 towards a distal 
10 end of the outer tube 10. As described herein, some conduit 
device 1 embodiments of the present invention may comprise 
a nut 20 operably engaged about an outer surface of the outer 
tube 10 proximal to the ring 30. In some such embodiments, 
the nut 20 may comprise threading on at least a portion on an 
15 inside surface thereof, wherein the threading is configured for 
cooperating with the threading 11 on at least a portion of the 
outside surface of the outer tube 10. The nut 20 may thus be 
configured to cooperate with the ring 30 to advance the ring 
30 towards the distal end of the outer tube 10, and therefore 
20 into contact with the first surface 8SS of the tissue wall 8SO. 
As shown in FIG. SE, the tissue core chamber 62 may thus be 
configured for receiving the tissue core 8SOa retrieved by 
retraction of the piercing rod 60 (and the retrieval device 61 25 
operably engaged with a distal end thereof). In order to allow 
As shown generally in FIG. SB, once the nut 20 and ring 30 
are advanced distally (which may be accomplished by hand-
tightening the nut 20), the ring 30 may cooperate with the 
attaching device lS such that at least a portion of the tissue 
wall 8SO is secured between the attaching device lS and the 
ring 30 so as to securely operably engage the outer tube 10 
with the tissue wall 8SO. 
As shown in FIG. SC, once the outer tube 10 is stabilized 
relative to the tissue wall 8SO, a coring device 2 (which, in 
some embodiments, as shown in FIG. 6, may be configured 
for carrying an inner tube 40), may be inserted into the guide 
aperture defined axially within the outer tube 10. As described 
herein with respect to FIG. 6, the coring device 2 may com-
prise a coring cylinder 6S configured for advancing through 
a clinician to positively identify and/or confirm the removal 
and retraction of the tissue core 8SOa, in some system 
embodiments at least a portion of the handle 63 may be 
provided with a substantially transparent material (such as a 30 
transparent polycarbonate polymer, for example) such that 
the tissue core 8SOa received by the tissue core chamber 62 
may be visible (to a clinician or an endoscopic imaging 
device, for example) from a position substantially outside the 
handle 63. 35 the conduit aperture defined by the inner tube 40 and through 
the tissue wall 8SO to define an aperture therein by removing 
a tissue core 8SOa (see FIG. SD, for example). Referring again 
to FIG. SC, some embodiments may further comprise a pierc-
ing rod 60 slidably advancable and retractable within the 
FIGS. SA-SG illustrate the various steps involved in the 
utilization of one embodiment of the system of the present 
invention for installing a conduit device 1 in a tissue wall 8SO 
(such as the ventricular apex). It should be understood that 
various embodiments of the present invention may be utilized 
for installing the conduit device 1 for use in medical proce-
dures that may include, but are not limited to: bypass; cardiac 
valve repair or replacement; attachment of a ventricular assist 
device; and combinations of such procedures. As shown in 
FIG. SA, an exemplary process for installing a conduit device 
1 may begin with the implantation of the attaching device lS 
in the tissue wall 8SO. As described herein, the attaching 
device lS may comprise a helical spring and/or coil config-
ured for advancing along a helical path at least partially 
through the tissue wall 8SO such that at least a portion of the 
attaching device 8SO becomes disposed substantially 
between the first surface 8SS and the opposing second surface 
8S3 of the tissue wall 8SO when the outer tube 10 is rotated 
relative to the first surface 8SS of the tissue wall 8SO. In some 
40 coring bore defined by the coring cylinder 6S. The piercing 
rod 60 may comprise, in some embodiments, an elongate 
proximal end that may be manipulated (i.e. extended and/or 
retracted) by a clinician in order to initially pierce the tissue 
wall 8SO and/or retract the tissue core 8SOa removed there-
45 from (as described further herein). As shown in FIGS. SD and 
SE, the piercing rod 60 may further comprise a retrieval 
device 61 operably engaged with a distal end thereof and 
configured for axially retaining the tissue core 8SOa removed 
by the coring cylinder 6S. The piercing rod 60 may be con-
50 figured for advancing so as to pierce the tissue wall 8SO prior 
to removal of the tissue core 8SOa (i.e. prior to advancement 
of the coring cylinder 6S). Furthermore, as shown in FIG. SE, 
the piercing rod 60 may be further configured for retracting 
after removal of the tissue core 8SOa such that the tissue core 
embodiments, the attaching device lS may be sized such that 55 
the axial length of the attaching device lS does not extend 
substantially distal to the second surface 8S3 of the tissue wall 
8SO. 
8SOa is retrievable via a proximal end of the coring device 2. 
As shown in FIGS. SD and 6, the coring device 2 may be 
further configured for carrying the inner tube 40 through the 
aperture such that the inner tube 40 extends at least partially 
through the aperture so as to establish fluid communication In some embodiments, wherein the attaching device com-
prises a conical and/or "radially-expanding" helix, the attach-
ing device lS may act to compress at least a portion of the 
tissue wall 8SO radially inward and towards an outer surface 
of the innertube 40 so as to establish a substantially fluid-tight 
seal between the outer surface of the inner tube 40 and the 
portion of the tissue wall 8SO that has been urged radially 
inward by the conical and/or radially-expanding helix of the 
attaching device lS. Furthermore, in embodiments wherein 
60 between the first and second surfaces 8SS, 8S3 of the tissue 
wall 8SO (see also, FIG. 3, for example). As described herein, 
with respect to various conduit device 1 embodiments of the 
present invention the outer tube 10 may comprise a first 
securing device 13 operably engaged with a proximal end 
65 thereof and the inner tube 40 (carried, for example, by the 
coring device 2 into position relative to the outer tube 10) may 
comprise a complementary second securing device 43 aper-
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ably engaged with a proximal end thereof. As shown gener-
ally in FIG. 3, the second securing device 43 (which may 
comprise a deformable pawl, for example) may be configured 
for selectively operably engaging the first securing device 13 
(which may comprise a complementary at least one ridge 
disposed on an outer surface of the outer tube 10) so as to 
positively and securely operably engage the inner tube 40 
with the outer tube 10. 
Referring again to FIG. SE, the coring device 2 may, in 
some embodiments, comprise a handle 63 operably engaged 10 
with a proximal end of the coring device 2. As described 
herein, the handle 63 may define a tissue core chamber 62 in 
communication with the coring bore defined, for example, by 
the coring cylinder 6S. The tissue core chamber 62 may thus 15 
be configured for receiving the tissue core 8SOa retrieved by 
retraction of the piercing rod 60 (and the retrieval device 61 
operably engaged with a distal end thereof). In some embodi-
ments, the coring device 2 may also define a fill aperture 
configured for operably engaging a source of saline solution 20 
or other fluid that may be used to substantially flood the 
coring bore defined by the coring cylinder 6S and the tissue 
core chamber 62 so as to reduce the chance of introducing gas 
bubbles (i.e. air bubbles) into an interior chamber defined by 
the tissue wall 8SO when the coring device 2 is introduced via 25 
the outer tube 10. 
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That which is claimed: 
1. A method for establishing fluid communication between 
a first surface and a second surface of a tissue wall, the method 
comprising: 
engaging the tissue wall with a conduit device such that a 
substantially fluid-tight seal is established between the 
conduit device and the tissue wall, the conduit device 
comprising an outer tube formed of a substantially rigid 
material; and 
after engaging the tissue wall with the conduit device, 
advancing a coring device through the outer tube of the 
conduit device and through the tissue wall to core an 
aperture in the tissue wall extending from the first sur-
face to the second surface of the tissue wall while main-
taining the substantially fluid-tight seal between the con-
duit device and the tissue wall. 
2. The method of claim 1, wherein the substantially fluid-
tight seal is established between the outer tube of the conduit 
device and the tissue wall. 
3. The method of claim 1, wherein the substantially fluid-
tight seal is established between a distal end of the outer tube 
of the conduit device and the tissue wall. 
4. The method of claim 1, wherein the conduit device 
further comprises a ring positioned about the outer tube, and 
wherein the substantially fluid-tight seal is established 
between the ring of the conduit device and the tissue wall. 
S. The method of claim 4, wherein the ring is positioned 
about a distal end of the outer tube. 
6. The method of claim 4, wherein the ring has a disc shape 
configured to abut the tissue wall. 
7. The method of claim 4, wherein the ring has a frusto-
conical shape configured to receive a portion of the tissue wall 
therein. 
8. The method of claim 1, wherein the conduit device 
further comprises a sealing member positioned about the 
outer tube, and wherein the substantially fluid-tight seal is 
established between the sealing member of the conduit device 
and the tissue wall. 
As described generally herein with regard to the various 
system embodiments of the present invention, the conduit 
device 1 installation process may advantageously allow a 
clinician to visually confirm that the tissue core 8SOa 30 
removed by the coring cylinder 6S has been completely and 
cleanly removed from the aperture defined in the tissue wall 
8SO. For example, in some embodiments, at least a portion of 
the handle 63 may comprise a transparent material such that 
the tissue core 8SOa received within the tissue core chamber 35 
62 may be directly visible by a clinician and/or an endoscopic 
imaging device from a position substantially outside the 
handle 63. As shown in FIGS. SF and SG, after the coring 
device 2 (and the tissue core 8SOa retained in the handle 63 
thereof) is retracted and removed from the inner tube 40, a 
clamp C may be applied to a proximal end of a graft portion 
that may be operably engaged with the inner tube 40 of the 
conduit device 1. In other embodiments, the inner tube 40 
may comprise one or more ridges defined on an outer surface 
9. The method of claim 8, wherein the sealing member is 
40 formed of an elastomeric material. 
of the proximal end thereof that may be configured forreceiv- 45 
ing a deformable cap or other cover for temporarily and/or 
semi-permanently closing the aperture defined by the 
installed conduit device 1. As described herein, the conduit 
device 1 may be utilized as a portion of a two-part bypass 
system that may comprise another corresponding conduit 50 
device 1 installed in a tissue wall 8SO defining a wall of the 
mammalian aorta, for example. The two corresponding con-
duit devices 1 may then be operably engaged with one another 
via a valve device so as to form an apicoaortic connection 
(AAC) in order to bypass, for example, a faulty valve or other 55 
mechanical defect present in a subject's cardiac anatomy. 
Many modifications and other embodiments of the inven-
tions set forth herein will come to mind to one skilled in the art 
10. The method of claim 1, further comprising, before 
advancing the coring device, attaching the conduit device to 
the tissue wall. 
11. The method of claim 10, wherein the conduit device 
further comprises an attaching device, and wherein attaching 
the conduit device to the tissue wall comprises advancing the 
attaching device at least partially through the tissue wall such 
that at least a portion of the attaching device is disposed 
substantially between the first surface and the second surface 
of the tissue wall. 
12. The method of claim 11, wherein the attaching device 
comprises a helical coil or a helical spring member. 
13. The method of claim 1, wherein the coring device 
comprises a coring tube. 
14. The method of claim 1, further comprising removing 
the coring device from the tissue wall while maintaining the 
substantially fluid-tight seal between the conduit device and 
the tissue wall. 
lS. The method of claim 1, further comprising removing 
60 the coring device from the outer tube of the conduit device 
while maintaining the substantially fluid-tight seal between 
the conduit device and the tissue wall. 
to which these inventions pertain having the benefit of the 
teachings presented in the foregoing descriptions and the 
associated drawings. Therefore, it is to be understood that the 
inventions are not to be limited to the specific embodiments 
disclosed and that modifications and other embodiments are 
intended to be included within the scope of the appended 
claims. Although specific terms are employed herein, they are 65 
used in a generic and descriptive sense only and not for 
purposes of limitation. 
16. The method of claim 1, further comprising inserting an 
inner tube of the conduit device through the outer tube of the 
conduit device and through the aperture in the tissue wall to 
maintain fluid communication between the first surface and 
the second surface of the tissue wall. 
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17. The method of claim 1, further comprising attaching a 
ventricular assist device to the tissue wall via the conduit 
device. 
18. The method of claim 1, wherein the tissue wall is a heart 
tissue wall. 
19. The method of claim 1, wherein the tissue wall is a 
ventricular wall of a beating heart. 
20. The method of claim 1, wherein engaging the tissue 
wall with the conduit device comprises engaging at least the 
first surface of the tissue wall with the conduit device. 
21. The method of claim 20, wherein the first surface of the 
tissue wall is an outer surface of the tissue wall, and wherein 
the second surface of the tissue wall is an inner surface of the 
tissue wall. 
10 
22. ~he method of claim 1, further comprising, before 15 
advancmg the coring device, fixing a position of the outer 
tube relative to the tissue wall. 
16 
ing at least partially through the tissue wall such that at least 
a portion of the attaching device is disposed substantially 
between the first surface and the second surface of the tissue 
wall. 
35. The system of claim 34, wherein the attaching device 
comprises a helical coil or a helical spring member. 
36. The system of claim 24, wherein the coring device 
comprises a coring tube. 
37. The system of claim 24, wherein the conduit device is 
configured to maintain the substantially fluid-tight seal 
between the conduit device and the tissue wall while the 
coring device is removed from the tissue wall. 
38. The system of claim 24, wherein the conduit device is 
configured to maintain the substantially fluid-tight seal 
between the conduit device and the tissue wall while the 
coring device is removed from the outer tube of the conduit 
device. 
39. The system of claim 24, wherein the conduit device 
23. l_he method of claim 1, further comprising, before the 
advancmg the coring device, assessing the seal established 
between conduit device and the tissue wall. 
24. A system for establishing fluid communication 
between a first surface and a second surface of a tissue wall 
the system comprising: ' 
a conduit device configured for engaging the tissue wall 
such that a substantially fluid-tight seal is established 
between the conduit device and the tissue wall the con-
duit device comprising an outer tube formed ~fa sub-
stantially rigid material; and 
20 further comprises an inner tube configured for inserting 
through the outer tube of the conduit device and through the 
aperture in the tissue wall to maintain fluid communication 
between the first surface and the second surface of the tissue 
wall. 
25 40. The system of claim 24, wherein the conduit device is 
configured for attaching a ventricular assist device to the 
tissue wall. 
a coring device configured for advancing through the outer 
tube and through the tissue wall to core an aperture in the 30 
tissue wall extending from the first surface to the second 
surface of the tissue wall after engaging the tissue wall 
with the conduit device and while maintaining the sub-
stantially fluid-tight seal between the conduit device and 
the tissue wall. 35 
25. The system of claim 24, wherein the outer tube of the 
conduit device is configured for engaging the tissue wall such 
that the substantially fluid-tight seal is established between 
the outer tube of the conduit device and the tissue wall. 
26. The system of claim 24, wherein a distal end of the 40 
~utertube of the conduit device is configured for engaging the 
tissue wall such that the substantially fluid-tight seal is estab-
lished between the distal end of the outer tube of the conduit 
device and the tissue wall. 
27. The system of claim 24, wherein the conduit device 45 
further comprises a ring positioned about the outer tube and 
configured for engaging the tissue wall such that the substan-
tially fluid-tight seal is established between the ring of the 
conduit device and the tissue wall. 
28. The system of claim 27, wherein the ring is positioned 50 
about a distal end of the outer tube. 
29. The system of claim 27, wherein the ring has a disc 
shape configured for abutting the tissue wall. 
30. The system of claim 27, wherein the ring has a frusto-
conical shape configured for receiving a portion of the tissue 55 
wall therein. 
31. The system of claim 24, wherein the conduit device 
further comprises a sealing member positioned about the 
outer tube and configured for engaging the tissue wall such 
that the substantially fluid-tight seal is established between 60 
the sealing member of the conduit device and the tissue wall. 
32. The system of claim 31, wherein the sealing member is 
formed of an elastomeric material. 
33. The system of claim 24, wherein the conduit device is 
configured for attaching to the tissue wall. 
34. The system of claim 33, wherein the conduit device 
further comprises an attaching device configured for advanc-
65 
41. The system of claim 24, wherein the tissue wall is a 
heart tissue wall. 
42. The system of claim 24, wherein the tissue wall is a 
ventricular wall of a beating heart. 
43. A method for establishing fluid communication 
between a first surface and a second surface of a tissue wall 
the method comprising: ' 
engaging the tissue wall with a conduit device such that a 
substantially fluid-tight seal is established between the 
conduit device and the tissue wall, the conduit device 
comprising an outer tube; 
after engaging the tissue wall with the conduit device 
advancing a coring device through the outer tube of th~ 
conduit device and through the tissue wall to core an 
aperture in the tissue wall extending from the first sur-
face to the second surface of the tissue wall while main-
taining the substantially fluid-tight seal between the con-
duit device and the tissue wall, the coring device 
comprising a coring tube; and 
inserting an inner tube through the outer tube of the conduit 
device and through the aperture in the tissue wall. 
44. A system for establishing fluid communication 
between a first surface and a second surface of a tissue wall 
the system comprising: ' 
a conduit device configured for engaging the tissue wall 
such that a substantially fluid-tight seal is established 
between the conduit device and the tissue wall the con-
duit device comprising an outer tube; ' 
a coring device configured for advancing through the outer 
tube and through the tissue wall to core an aperture in the 
tissue wall extending from the first surface to the second 
surface of the tissue wall after engaging the tissue wall 
with the conduit device and while maintaining the sub-
stantially fluid-tight seal between the conduit device and 
the tissue wall, the coring device comprising a coring 
tube; and 
an inner tube configured for inserting through the outer 
tube of the conduit device and through the aperture in the 
tissue wall. 
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